Advances in our understanding of diabetic retinopathy. (Q38088818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Advances in our understanding of diabetic retinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Reinhold J Medina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Tim M. Curtis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Noemi Lois

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Peter Adamson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

13 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

1-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

The worldwide diabetes epidemic

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Global prevalence and major risk factors of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Diabetic retinopathy screening: a systematic review of the economic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Pathophysiology of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Targeting the pathophysiology of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

A prospective, non comparative, multicenter study to investigate the effect of cadexomer iodine on bioburden load and other wound characteristics in diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Epigenetics: mechanisms and implications for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The role of epigenetics in the pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular lesions in diabetes are distributed non-uniformly within the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Basement membrane abnormalities in human eyes with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Increased expression of basement membrane collagen in human diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Aging increases retinal vascular lesions characteristic of early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Inhibition of advanced glycation end‐products protects against retinal capillary basement membrane expansion during long‐term diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Pericytes and the pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Fluorescein angiography of the fundus in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Renal vascular abnormalities in Bardet-Biedl syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Death of retinal neurons in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Paired-flash identification of rod and cone dysfunction in the diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The retinal blood flow in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Ocular perfusion abnormalities in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Ocular blood flow and associated functional deviations in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Relationship of retinal vessel caliber to cardiovascular disease and mortality in African Americans with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Inflammation in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Microglial activation in human diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Intraretinal pH in diabetic cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Para-inflammation in the aging retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The Ins2Akita mouse as a model of early retinal complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

AGEs, RAGE, and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The RAGE axis in early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular permeability in ocular disease and the role of tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

MRI retinovascular studies in humans: research in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Significance of outer blood-retina barrier breakdown in diabetes and ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Development and pathology of the hyaloid, choroidal and retinal vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular endothelial cell growth factor-a: not just for endothelial cells anymore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

A brief history of anti-VEGF for the treatment of ocular angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Role of NADPH oxidase in retinal vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Manipulating angiogenesis in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The expression of membrane-associated 67-kDa laminin receptor (67LR) is modulated in vitro by cell-contact inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Expression of the 67 kDa laminin receptor (67LR) during retinal development: correlations with angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Involvement of Progenitor Cells in Vascular Repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Vascular stem cells and ischaemic retinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Endothelial progenitor cells in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

A perivascular origin for mesenchymal stem cells in multiple human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120588

21 January 2018

Identifiers

DOI

10.1042/CS20120588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23485060%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference